IL185113A - Converted pyridine derivatives, pharmaceuticals containing it, and its use in drug preparation - Google Patents

Converted pyridine derivatives, pharmaceuticals containing it, and its use in drug preparation

Info

Publication number
IL185113A
IL185113A IL185113A IL18511307A IL185113A IL 185113 A IL185113 A IL 185113A IL 185113 A IL185113 A IL 185113A IL 18511307 A IL18511307 A IL 18511307A IL 185113 A IL185113 A IL 185113A
Authority
IL
Israel
Prior art keywords
alk
cycloalk
dimethyl
pyridin
morpholin
Prior art date
Application number
IL185113A
Other languages
English (en)
Hebrew (he)
Other versions
IL185113A0 (en
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2006/000123 external-priority patent/WO2006092143A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL185113A0 publication Critical patent/IL185113A0/en
Publication of IL185113A publication Critical patent/IL185113A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL185113A 2005-03-03 2007-08-07 Converted pyridine derivatives, pharmaceuticals containing it, and its use in drug preparation IL185113A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500321 2005-03-03
PCT/DK2006/000123 WO2006092143A1 (en) 2005-03-03 2006-03-02 Substituted pyridine derivatives

Publications (2)

Publication Number Publication Date
IL185113A0 IL185113A0 (en) 2007-12-03
IL185113A true IL185113A (en) 2013-10-31

Family

ID=37908541

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185113A IL185113A (en) 2005-03-03 2007-08-07 Converted pyridine derivatives, pharmaceuticals containing it, and its use in drug preparation

Country Status (14)

Country Link
KR (2) KR20070108884A (es)
CN (3) CN102516165A (es)
AR (1) AR052931A1 (es)
BR (1) BRPI0608122A2 (es)
DK (1) DK2298766T3 (es)
EA (1) EA016244B1 (es)
ES (1) ES2433593T3 (es)
HK (1) HK1164868A1 (es)
IL (1) IL185113A (es)
NZ (1) NZ556613A (es)
PT (1) PT2298766E (es)
SI (1) SI2298766T1 (es)
UA (1) UA92340C2 (es)
ZA (1) ZA200705987B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114409593B (zh) * 2022-01-20 2024-02-23 上海泾维化工科技有限公司 一种2-氨基-5-甲基吡啶的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60037321T4 (de) * 1999-08-04 2010-01-07 Icagen, Inc. Benzanilide als öffner des kaliumkanals
MXPA03000032A (es) * 2000-06-29 2003-08-19 Neurosearch As Uso de derivados de oxindol 3-sustituidos como moduladores de los canales de potasio kcnq.
HUP0303841A2 (hu) * 2001-02-20 2004-03-01 Bristol-Myers Squibb Company 2,4-Diszubsztituált-5-pirimidinkarboxamid-származékok mint KCNQ káliumcsatorna modulátorok és ezeket tartalmazó gyógyszerkészítmények és előállításuk
MXPA05010000A (es) * 2003-03-21 2005-11-17 Lundbeck & Co As H Derivados de p-diaminobenceno substituidos.
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives

Also Published As

Publication number Publication date
EA200701877A1 (ru) 2008-02-28
UA92340C2 (en) 2010-10-25
CN102276523B (zh) 2014-12-10
AR052931A1 (es) 2007-04-11
DK2298766T3 (da) 2013-11-11
ZA200705987B (en) 2009-05-27
ES2433593T3 (es) 2013-12-11
SI2298766T1 (sl) 2014-05-30
CN102276523A (zh) 2011-12-14
IL185113A0 (en) 2007-12-03
BRPI0608122A2 (pt) 2010-11-09
EA016244B1 (ru) 2012-03-30
KR20070108884A (ko) 2007-11-13
NZ556613A (en) 2010-11-26
PT2298766E (pt) 2013-11-07
HK1164868A1 (en) 2012-09-28
CN101133053A (zh) 2008-02-27
KR20130088905A (ko) 2013-08-08
CN102516165A (zh) 2012-06-27

Similar Documents

Publication Publication Date Title
AU2006220130B2 (en) Substituted pyridine derivatives
US7812023B2 (en) Methods of using substituted morpholine derivatives
IL185113A (en) Converted pyridine derivatives, pharmaceuticals containing it, and its use in drug preparation
MXPA06010329A (es) Derivados sustituidos de morfolina y tiomorfolina

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees